These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23271213)
1. Primary gastrointestinal follicular lymphoma with histological transformation. Hangai S; Nakamura F; Kamikubo Y; Ichikawa M; Suzuki H; Yoshida S; Yamada A; Takazawa Y; Fukayama M; Koike K; Kurokawa M Ann Hematol; 2013 Jul; 92(7):993-4. PubMed ID: 23271213 [No Abstract] [Full Text] [Related]
2. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy]. Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588 [TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy. Falorio S; Angrilli F; Fioritoni G Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763 [No Abstract] [Full Text] [Related]
4. [Clinical analysis of eight patients with primary follicular lymphoma in the duodenum]. Tsujioka T; Wada H; Yata K; Kondo T; Suemori S; Tokunaga H; Ohmori K; Kubo Y; Nakanishi H; Mikami M; Haruma K; Sadahira Y; Sugihara T Rinsho Ketsueki; 2007 Feb; 48(2):134-9. PubMed ID: 17370641 [TBL] [Abstract][Full Text] [Related]
5. Disseminated diffuse large B cell lymphoma of bone on PET scan. Chen WL; Ho CL Int J Hematol; 2008 Jul; 88(1):1-2. PubMed ID: 18478313 [No Abstract] [Full Text] [Related]
6. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial. Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542 [TBL] [Abstract][Full Text] [Related]
7. Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT. Seshadri N; Ananthasivan R; Kavindran R; Srikanth G; Chandra S Cancer Imaging; 2010 Oct; 10(1):194-7. PubMed ID: 20926362 [TBL] [Abstract][Full Text] [Related]
8. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS. Dupuis J; Berriolo-Riedinger A; Julian A; Brice P; Tychyj-Pinel C; Tilly H; Mounier N; Gallamini A; Feugier P; Soubeyran P; Colombat P; Laurent G; Berenger N; Casasnovas RO; Vera P; Paone G; Xerri L; Salles G; Haioun C; Meignan M J Clin Oncol; 2012 Dec; 30(35):4317-22. PubMed ID: 23109699 [TBL] [Abstract][Full Text] [Related]
9. [Management of follicular lymphoma]. Izutsu K Rinsho Ketsueki; 2014 Oct; 55(10):1929-36. PubMed ID: 25297757 [No Abstract] [Full Text] [Related]
10. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911 [TBL] [Abstract][Full Text] [Related]
11. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications]. Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527 [TBL] [Abstract][Full Text] [Related]
12. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy. Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801 [TBL] [Abstract][Full Text] [Related]
13. Follicular lymphoma: 2012 update on diagnosis and management. Freedman A Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911 [TBL] [Abstract][Full Text] [Related]
15. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma. Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734 [TBL] [Abstract][Full Text] [Related]
16. [A case of follicular lymphoma with onset of chylothorax]. Hanaoka N; Nagao H; Murakami T; Chijiwa T; Suganuma T Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):31-5. PubMed ID: 17313024 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087 [TBL] [Abstract][Full Text] [Related]
18. [Occipital neuralgia (Arnold) as the presenting symptom of diffuse large B-cell non-Hodgkin lymphoma]. Bruneau O; Le Moigne F; Guyotat J; Nicolas-Virelizier E; Guilloton L; Drouet A Rev Neurol (Paris); 2013 Feb; 169(2):175-8. PubMed ID: 23079854 [No Abstract] [Full Text] [Related]
19. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid. Bibb J; Hromas R; Rabinowitz I J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654 [No Abstract] [Full Text] [Related]